Zynex Share Price Today
(NASDAQ: ZYXI)

Name: Zynex Share Price Today (NASDAQ: ZYXI) - Zynex Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Zynex share price is $7.23 & ₹628.79 as on 6 Mar 2025, 2.30 'hrs' IST

$7.23

▲

-0.12

(-1.63%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Zynex share price in Dollar and Rupees. Guide to invest in Zynex stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Zynex, along with analyst recommendations, forecasts, and comprehensive financials.

Zynex share price movements

Today's Low: $7.21
Today's High: $7.43
$7.23
0.28%
Downside
Day's Volatility :2.96%
Upside
2.69%
52 Weeks Low: $7.01
52 Weeks High: $13.19
$7.23
3.04%
Downside
52 Weeks Volatility :46.85%
Upside
45.19%

Zynex (ZYXI) Returns

Period	Zynex Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.94%	3.7%	0.0%
6 Months	-8.37%	-2.8%	0.0%
1 Year	-43.21%	2.5%	0.0%
3 Years	29.8%	12.9%	-11.6%

Zynex (ZYXI) Key Statistics

in dollars & INR

Previous Close	$7.35
Open	$7.35
Today's High	$7.43
Today's Low	$7.21
Market Capitalization	$230.2M
Today's Volume	$39.3K
52 Week High	$13.19
52 Week Low	$7.0101
Revenue TTM	$193.7M
EBITDA	$13.5M
Earnings Per Share (EPS)	$0.14
PE Ratio	51.64
Profit Margin	2.49%
Quarterly Earnings Growth YOY	-0.3%
Return On Equity TTM	10.23%

How to invest in Zynex Stock (ZYXI) from India?

It is very easy for Indian residents to invest directly in Zynex from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zynex stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zynex or ZYXI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zynex or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zynex shares which would translate to 0.120 fractional shares of Zynex as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zynex, in just a few clicks!

Returns in Zynex (ZYXI) for Indian investors in Rupees

The Zynex stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Zynex investment value today

Current value as on today

₹61,744

Returns

₹38,256

(-38.26%)

Returns from Zynex Stock

₹43,205 (-43.21%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Zynex (ZYXI)

-57%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Zynex Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Zynex

BlackRock Inc
3.90%
Vanguard Group Inc
3.33%
Hotchkis & Wiley Capital Management LLC
1.73%
Nantahala Capital Management, LLC
1.54%
Geode Capital Management, LLC
1.39%
State Street Corp
1.14%

Analyst Recommendation on Zynex

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Zynex(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Zynex Stock (ZYXI)

What analysts predicted

Upside of 142.05%

Target:

$17.50

Current:

$7.23

Insights on Zynex Stock (Ticker Symbol: ZYXI)

Price Movement
In the last 1 year, ZYXI stock has moved down by -43.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 46.53M → 49.96M (in $), with an average increase of 3.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 10.0K → 2.38M (in $), with an average increase of 74.0% per quarter
ZYXI vs MCK (1 yr)
In the last 1 year, Mckesson Corporation has given 21.8% return, outperforming this stock by 65.0%
ZYXI vs CAH (3 yr)
In the last 3 years, Cardinal Health, Inc. has given 127.0% return, outperforming this stock by 90.1%
Price to Sales
ForZYXI every $1 of sales, investors are willing to pay $1.2, whereas for Mckesson Corporation, the investors are paying $0.2 for every $1 of sales.

ZYXI Zynex Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$31.9M	↑ 36.21%
Net Income	$9.6M	↑ 29.69%
Net Profit Margin	29.93%	↓ 1.5%

	FY19	Y/Y Change
Revenue	$45.5M	↑ 42.47%
Net Income	$9.5M	↓ 0.63%
Net Profit Margin	20.87%	↓ 9.06%

	FY20	Y/Y Change
Revenue	$80.1M	↑ 76.2%
Net Income	$9.1M	↓ 4.4%
Net Profit Margin	11.33%	↓ 9.54%

	FY21	Y/Y Change
Revenue	$130.3M	↑ 62.63%
Net Income	$17.1M	↑ 88.48%
Net Profit Margin	13.13%	↑ 1.8%

	FY22	Y/Y Change
Revenue	$158.2M	↑ 21.39%
Net Income	$17.0M	↓ 0.32%
Net Profit Margin	10.78%	↓ 2.35%

	FY23	Y/Y Change
Revenue	$184.3M	↑ 16.54%
Net Income	$9.7M	↓ 42.91%
Net Profit Margin	5.28%	↓ 5.5%

	Q2 FY23	Q/Q Change
Revenue	$45.0M	↑ 6.6%
Net Income	$3.4M	↑ 113.77%
Net Profit Margin	7.46%	↑ 3.74%

	Q3 FY23	Q/Q Change
Revenue	$49.9M	↑ 11.04%
Net Income	$3.6M	↑ 7.16%
Net Profit Margin	7.2%	↓ 0.26%

	Q4 FY23	Q/Q Change
Revenue	$47.3M	↓ 5.27%
Net Income	$1.2M	↓ 66.19%
Net Profit Margin	2.57%	↓ 4.63%

	Q1 FY24	Q/Q Change
Revenue	$46.5M	↓ 1.59%
Net Income	$10.0K	↓ 99.18%
Net Profit Margin	0.02%	↓ 2.55%

	Q2 FY24	Q/Q Change
Revenue	$49.9M	↑ 7.2%
Net Income	$1.2M	↑ 12070.0%
Net Profit Margin	2.44%	↑ 2.42%

	Q3 FY24	Q/Q Change
Revenue	$50.0M	↑ 0.17%
Net Income	$2.4M	↑ 95.73%
Net Profit Margin	4.77%	↑ 2.33%

	FY18	Y/Y Change
Profit	$25.9M	↑ 39.04%

	FY19	Y/Y Change
Profit	$36.7M	↑ 41.65%

	FY20	Y/Y Change
Profit	$62.7M	↑ 71.05%

	FY21	Y/Y Change
Profit	$103.0M	↑ 64.23%

	FY22	Y/Y Change
Profit	$126.2M	↑ 22.51%

	FY23	Y/Y Change
Profit	$146.0M	↑ 15.69%

	Q2 FY23	Q/Q Change
Profit	$35.7M	↑ 8.45%

	Q3 FY23	Q/Q Change
Profit	$40.4M	↑ 13.12%

	Q4 FY23	Q/Q Change
Profit	$37.0M	↓ 8.3%

	Q1 FY24	Q/Q Change
Profit	$37.2M	↑ 0.59%

	Q2 FY24	Q/Q Change
Profit	$39.9M	↑ 7.2%

	Q3 FY24	Q/Q Change
Profit	$39.8M	↓ 0.31%

	FY18	Y/Y Change
Operating Cash Flow	$9.4M	↑ 13.9%
Investing Cash Flow	$-1.1M	↑ 1143.68%
Financing Cash Flow	$-3.8M	↑ 31.8%

	FY19	Y/Y Change
Operating Cash Flow	$6.3M	↓ 33.0%
Investing Cash Flow	$-160.0K	↓ 85.21%
Financing Cash Flow	$-2.2M	↓ 40.71%

	FY20	Y/Y Change
Operating Cash Flow	$818.0K	↓ 87.02%
Investing Cash Flow	$-985.0K	↑ 515.63%
Financing Cash Flow	$25.3M	↓ 1234.02%

	FY21	Y/Y Change
Operating Cash Flow	$6.9M	↑ 749.51%
Investing Cash Flow	$-16.6M	↑ 1585.89%
Financing Cash Flow	$13.1M	↓ 48.24%

	FY22	Y/Y Change
Operating Cash Flow	$13.7M	↑ 97.81%
Investing Cash Flow	$-418.0K	↓ 97.48%
Financing Cash Flow	$-35.8M	↓ 373.34%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$741.0K	↓ 61.69%
Investing Cash Flow	$-210.0K	↑ 20.69%
Financing Cash Flow	$41.4M	↓ 910.37%

Zynex Technicals Summary

Sell

Neutral

Buy

Zynex is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Zynex (ZYXI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zynex Inc	-10.3%	-8.37%	-43.21%	29.8%	-35.91%
Cardinal Health, Inc.	1.8%	14.0%	15.19%	143.03%	165.85%
Mckesson Corporation	6.02%	24.26%	21.82%	129.73%	384.67%
Henry Schein, Inc.	-11.32%	2.29%	-5.14%	-17.73%	31.1%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zynex Inc	51.64	51.64	0.0	0.2	0.1	0.04	NA	1.12
Cardinal Health, Inc.	23.52	23.52	0.84	7.95	0.0	0.03	0.02	-12.36
Mckesson Corporation	29.58	29.58	1.11	32.76	0.0	0.05	0.0	-24.48
Henry Schein, Inc.	23.28	23.28	1.72	4.88	0.08	0.04	NA	27.33

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zynex Inc	Buy	$230.2M	-35.91%	51.64	2.49%
Cardinal Health, Inc.	Hold	$30.5B	165.85%	23.52	0.59%
Mckesson Corporation	Buy	$80.7B	384.67%	29.58	0.82%
Henry Schein, Inc.	Hold	$8.7B	31.1%	23.28	3.08%

About Zynex

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Organization	Zynex
Employees	1100
CEO	Mr. Thomas Sandgaard
Industry	Medical Specialties

Management People of Zynex

Name	Title
Mr. Thomas Sandgaard	Founder, President, CEO & Chairman
Mr. Daniel J. Moorhead CPA	Chief Financial Officer
Ms. Anna Lucsok	Chief Operating Officer
Mr. Steve Fox	Executive Vice President of Sales
Mr. Donald Gregg	President of Zynex Monitoring Solutions
Mr. Neil Friery	President & COO of Zynex Monitoring Solutions, Inc.

Important FAQs about investing in ZYXI Stock from India :

What is Zynex share price today?

Zynex share price today stands at $7.23, Open: $7.35 ; Previous Close: $7.35 ; High: $7.43 ; Low: $7.21 ; 52 Week High: $13.19 ; 52 Week Low: $7.01.

The stock opens at $7.35, after a previous close of $7.35. The stock reached a daily high of $7.43 and a low of $7.21, with a 52-week high of $13.19 and a 52-week low of $7.01.

Can Indians buy Zynex shares?

Yes, Indians can invest in the Zynex (ZYXI) from India.

With INDmoney, you can buy Zynex at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zynex at zero transaction cost.

How can I buy Zynex shares from India?

It is very easy to buy Zynex from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zynex (ZYXI) be purchased?

Yes, you can buy fractional shares of Zynex with INDmoney app.

What are the documents required to start investing in Zynex stocks?

To start investing in Zynex, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.